Dado oficial do INPI

BR500000501915938

Essa marca aparece no histórico oficial do INPI.

Mesmo quando o status está encerrado, o histórico ajuda a calibrar o risco, evitar repetição de erros e definir uma estratégia segura de naming.

Aguardando prazo de apresentação de oposiçãoTipo: FigurativaEscritório: Brasil

Ativar vigilância desta marca Falar com especialista

Snapshot rápido

ST13

BR500000501915938

Classe

5, 16, 35, 41, 42, 44

Pedido

501915938

Registro

501915938

Ver no INPI

Andamento no INPI

Prazo de oposição aberto

Depósito02/03/26
Publicação25/08/26
Exame
Deferimento
Concessão
Vigente

Pedido publicado na RPI em 25/08/2026. Qualquer interessado pode apresentar oposição até 24/10/2026.

Prazo para terceiros se oporem:24/10/2026(faltam 13 dias)

Última movimentação publicada pelo INPI: 25/08/2026. Atualizamos a cada nova RPI, publicada semanalmente.

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Situação INPI

Aguardando prazo de apresentação de oposição

Tipo de processo

Pedido de registro

Eventos registrados

Atualização mais recente

25/08/2026

Tipo de marca

Figurativa

Classes Nice

5, 16, 35, 41, 42, 44

Data de depósito

02/03/2026

Data de registro

Data de expiração

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Natureza

Madri Produto/Serviço

Escritório responsável

Brasil

Tipo de titular

NÃO RESIDENTE

Localização do titular

Titulares e representantes

Titulares

Acadia Pharmaceuticals Inc.

Representantes

Sem dados de representantes.

Classificação técnica

Classes Nice

Classe 5Classe 16Classe 35Classe 41Classe 42Classe 44

Códigos Vienna

1.1.21.1.251.1.10

Produtos e serviços

Classe 5

Pharmaceutical preparations for the treatment and prevention of neurologic, rare neurologic, neuropsychiatric, rare neuropsychiatric, metabolic, rare metabolic, genetic, rare genetic, psychologic, rare psychologic, psychiatric, and rare psychiatric diseases and disorders

Classe 16

Printed publications, namely, brochures, pamphlets, newsletters, written articles and guidebooks in the field of medical information and patient support

Classe 35

Promoting awareness of patient support offerings for neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric diseases and disorderspromoting awareness of patient support offerings for pain associated with neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric diseases and disordersbusiness administration services in the field of healthcare, namely, business administration of reimbursement and medical benefit information for neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric conditions and their treatmentbusiness administration services in the field of healthcare, namely, business administration of reimbursement and medical benefit information for treatment of pain associated with neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric conditionsbusiness administrative services for medical referrals

Classe 41

Educational services, namely, conducting programs in the field of neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric diseases and disorders and treatment and patient support options for these conditions

Classe 42

Providing on-line non-downloadable software for administering medical benefits and enrolling in benefits patient support program servicesbiomedical research servicesindustrial research in the field of biotechnologyscientific researchscientific and technological services, namely, research and design in the field of biotechnology and biomedicineproviding scientific research information in the field of biotechnology and biomedicinechemical, biochemical, biological and bacteriological research and analysisbiological research and analysistesting of pharmaceuticalsproviding medical and scientific research information in the field of pharmaceuticals and clinical trialspharmaceutical research and developmentpharmaceutical research in the field of medical testing, namely, in vitro and in vivo preclinical testing of potential drugsproviding medical research information in the field of pharmaceuticals

Classe 44

Consultancy in the field of the medical treatment of neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric conditionsconsultancy in the field of the medical diagnosis of neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric conditionsmedical informationproviding medical information via a websiteproviding personalized healthcare and medical information in the nature of providing information about the therapeutic benefits of pharmaceutical products, medical information regarding disease management, and healthcare-related information to patients and healthcare professionals in the fields of neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric diseases and disordersproviding medical information in the field of neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric diseases and disorders